4//SEC Filing
ALBINI EDWARD C 4
Accession 0001415889-25-013618
CIK 0001382101other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:11 PM ET
Size
16.9 KB
Accession
0001415889-25-013618
Insider Transaction Report
Form 4
ALBINI EDWARD C
CFO AND SECRETARY
Transactions
- Exercise/Conversion
Common Stock
2025-05-15+9,125→ 176,800 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-05-15−24,438→ 27,312 totalExp: 2028-03-01→ Common Stock (24,438 underlying) - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-05-15−11,156→ 4,594 totalExp: 2027-03-01→ Common Stock (11,156 underlying) - Exercise/Conversion
Common Stock
2025-05-15+11,156→ 167,675 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-05-15−9,125→ 0 totalExp: 2026-03-04→ Common Stock (9,125 underlying) - Exercise/Conversion
Common Stock
2025-05-15+24,438→ 156,519 total - Tax Payment
Common Stock
2025-05-15$0.88/sh−15,995$14,076→ 160,805 total
Footnotes (6)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.
- [F4]The reported transactions represent the accelerated vesting of certain of the reporting person's equity awards outstanding under the issuer's 2018 Equity Incentive Plan, in connection with his separation and transition from his position with the issuer, as previously reported by the issuer in its Current Report filed with the Securities and Exchange Commission on Form 8-K on March 13, 2025.
- [F5]The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date.
- [F6]The RSUs vest as to 1/4th of the total award annually beginning on March 4, 2023, subject to continued service through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001240014
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:11 PM ET
- Size
- 16.9 KB